Related by context. All words. (Click for frequent words.) 64 Cardiovascular Disease 63 Hypertension 62 atherosclerosis 61 Insulin Resistance 61 Ischemic 60 Aggressive Reduction 60 Atherosclerosis Research 60 Cardiovascular Diseases 60 Pancreatic 60 Metabolic Disease 60 Lipid Metabolism 60 Fibrosis 59 Adiposity 59 Stroke Prevention 59 Cognitive Decline 59 Autoimmune Diseases 59 atherosclerotic disease 59 Multiethnic Study 59 Thromboembolic 59 Diabetic Retinopathy 59 Arteriosclerosis 59 Nonalcoholic Fatty Liver Disease 58 Prediabetes 58 Hypercholesterolemia 58 Endothelial 58 Inflammation 58 Hyperlipidemia 58 Breast Cancer Metastasis 58 Oxidative Stress 58 Cachexia 58 Pulmonary Hypertension 58 Cardiovascular Events 58 Lipid Lowering Treatment 58 Thromboembolism 58 Liver Cancer 58 Preterm Delivery 58 atherosclerotic 58 Atherosclerotic 58 Interstitial Lung Disease 57 Cognitive Impairment 57 Diabetes Obesity 57 Idiopathic 57 Malignancies 57 Hypertrophy 57 Peripheral Arterial 57 Minimally Invasive Treatment 57 Ischemic Stroke 57 Metastases 57 cardiac hypertrophy 57 Neovascular Age Related Macular 57 Neoplasms 57 Cognitive Deficits 57 Autoimmunity 57 Angiogenesis 57 Cardiovascular Outcomes 57 Calcification 57 Allergic Rhinitis 57 Treating Chronic 57 Diabetes Mellitus 57 Cholesterol Levels SPARCL 57 Vascular Diseases 57 Vascular Disease 57 Cirrhosis 57 Invasive Breast Cancer 57 Bladder Cancer 57 Ventricular Tachycardia 56 Metabolism 56 Cardiovascular Risk 56 Osteoporosis 56 Randomized Study 56 Coronary Artery Calcium 56 Clinical Efficacy 56 Hepatocellular Carcinoma 56 Non Alcoholic Steatohepatitis 56 Movement Disorder 56 Microalbuminuria 56 Peripheral arterial disease 56 Postmenopausal Women 56 Gastric Cancer 56 Myocardial Ischemia 56 Aortic Stenosis 56 Kidney Disease 56 Heart Disease 56 Neuropathic Pain 56 Eye Diseases 56 Arrhythmias 56 Antiplatelet 56 Neurological Diseases 56 AA Amyloidosis 56 Ischaemic 56 Benign Prostatic Hyperplasia 56 Surgical Treatment 56 Therapeutic Targets 56 Immune Mediated 56 Wet AMD 56 Breast Cancer Recurrence 55 Bronchiectasis 55 Dyslipidemia 55 Metabolic Syndrome 55 Myocardial Infarction 55 Autoimmune Disease 55 Chronic Heart Failure 55 Diabetes Complications 55 Cardiac Arrhythmias 55 Prospective Randomized 55 Acute Myocardial Infarction 55 Non Alcoholic Fatty 55 Severe Asthma 55 Pathogenesis 55 Cardiovascular Mortality 55 Antihypertensive 55 Diabetic Patients 55 Lipoprotein 55 Renal Artery 55 Molecular Basis 55 Adenoma 55 Heart Failure 55 Neurodegenerative Disorders 55 Venous Thromboembolism 55 Therapeutic Effects 55 Autoimmune Disorders 55 Hypertriglyceridemia 55 Vulnerable Plaque 55 Peripheral Artery Disease 55 Neurodegenerative Disease 55 Eye Disease 55 familial hypercholesterolemia 55 Endothelial Function 55 Parkinsonism 55 Preeclampsia 55 Renal Disease 55 Coronary Arteries 55 Hemochromatosis 55 chronic thromboembolic pulmonary 55 Hypotension 55 Liver Disease 55 Thrombophilia 55 atherothrombotic disease 55 Etiology 55 Adenocarcinoma 55 Aortic stenosis 55 Heart Failure Patients 55 Inflammatory Bowel Disease 55 Sudden Cardiac Death 55 Mouse Model 55 Malignant Melanoma 55 Osteoarthritis 55 Investigational Treatment 54 Meta Analysis 54 Genetic Variation 54 Inflammatory Bowel Diseases 54 Effective Treatments 54 Bone Fractures 54 Neurochemistry 54 Inflammatory Markers 54 Coronary Artery Disease 54 left ventricular hypertrophy 54 Thiazolidinediones 54 Impaired Glucose Tolerance 54 Neurological Disorder 54 Soft Tissue Sarcoma 54 Diabetic Neuropathy 54 Skeletal Muscle 54 Esophageal 54 Diabetic Nephropathy 54 carotid atherosclerosis 54 Pancreatitis 54 Newly Diagnosed 54 Retinopathy 54 Neurodegenerative 54 Barrett Esophagus 54 Dysplasia 54 Insulin Sensitivity 54 Cutaneous T 54 Subarachnoid hemorrhage 54 Periodontitis 54 Beneficial Effects 54 Coronary artery disease 54 Coronary Heart Disease 54 Advanced Renal Cell 54 Carcinoma 54 Bucindolol 54 Pulmonary Arterial Hypertension 54 Neurodegeneration 54 Cardiovascular 54 Clinical Outcome 54 Mouse Models 54 Acute Stroke 54 Glucosamine Chondroitin Arthritis 54 Multicenter Randomized 54 Chronic Lymphocytic Leukemia 54 Thrombotic 54 Glucocorticoid 54 Risk Stratification 54 Castration Resistant Prostate Cancer 54 leiomyomas 54 Lowers Risk 54 Peripheral Arterial Disease 54 Critical Limb Ischemia CLI 54 Glioma 54 Brain Disorders 54 Hyponatremia 54 Chronic obstructive pulmonary 54 Psychiatric Disorders 54 Peripheral Vascular Disease 54 Carotid Stenting 54 Subgroup Analysis 54 Lipodystrophy 54 abdominal adiposity 54 Cardiotoxicity 54 Hematologic 54 Severe Sepsis 54 Molecular Mechanism 54 Polymorphism 54 Thrombosis 54 Hypothyroidism 54 Dose Response 54 hyperhomocysteinemia 53 ischemic stroke 53 Left Ventricular Hypertrophy 53 Dendritic Cells 53 PAOD 53 Signaling Pathway 53 Renal Cell Carcinoma 53 Rheumatoid 53 Venous thromboembolism 53 Vascular Medicine 53 nonalcoholic fatty liver 53 Pituitary 53 Female Urology 53 Inflammatory Arthritis 53 atherothrombotic 53 Occlusive Disease 53 Apoptosis 53 Bone Metastases 53 Aneurysm Repair 53 Cholangiocarcinoma 53 IDDM 53 Dialysis Outcomes 53 Alzheimers Disease 53 Multi Ethnic Study 53 Oxidized LDL 53 Artery Disease 53 Arterial Disease 53 Islet Transplant 53 Acute Myocardial 53 insulin resistance 53 Increased Mortality 53 Lipids 53 Slows Progression 53 Etanercept 53 See CLINICAL PHARMACOLOGY 53 Cerebrovascular 53 Cardiovascular Imaging 53 Adenomas 53 NAFLD 53 Respiratory Infections 53 Preterm Birth 53 Stem Cell Transplant 53 Sjogren Syndrome 53 Malformations 53 Molecular Mechanisms 53 Ovarian Cancer Risk 53 disease NAFLD 53 optic neuropathy 53 Fibrates 53 Prehypertension 53 Overactive Bladder 53 Drug Prevents 53 Systematic Review 53 Meningiomas 53 Solid Tumors 53 Neurological Disease 53 Urinary Incontinence 53 Anticoagulants 53 Parkinson Disease PD 53 Kidney Function 53 Oral Fingolimod 53 Hematological 53 Periodontal Disease 53 Chimeric 53 Cognitive Function 53 homozygous familial hypercholesterolemia 53 Chronic Kidney Disease 53 ACE Inhibitors 53 endothelial dysfunction 53 Lung Injury 53 Lung Function 53 Diabetic nephropathy 53 Ischemic Heart Disease 53 Neurodegenerative Diseases 53 cardiac conduction 53 diabetic nephropathy 53 Genetic Variant 53 Protein Linked 53 Phenotype 53 Iron Deficiency 53 Statin Therapy 53 complement inhibitor eculizumab 53 ST Elevation Myocardial 53 Patient Outcomes 53 Endocrinology 53 Blood Flow 53 Novel Treatments 53 Immunosuppression 53 nonalcoholic steatohepatitis NASH 53 Carcinomas 53 Advanced Melanoma 53 Frontotemporal Dementia 53 Inflammatory Diseases 53 Hyperglycemia 53 Fracture Risk 53 Acute Liver Failure 53 Myelodysplastic Syndrome MDS 53 Fatty Liver Disease 53 Inflammatory Disease 53 Neuroprotection 53 interstitium 53 Neuropathology 53 motor neuron degeneration 53 hyperparathyroidism 53 Juvenile Idiopathic Arthritis 53 Multicenter Study 53 microalbuminuria 53 Hypoparathyroidism 52 Cell Transplant 52 ST Segment Elevation 52 Osteopenia 52 Gastroparesis 52 Hyperkalemia 52 Pulmonary hypertension 52 Infarction 52 Ischemia 52 juvenile idiopathic arthritis 52 Neuroendocrine Tumors 52 Levels Linked 52 Atypical Hemolytic Uremic Syndrome 52 arteries atherosclerosis 52 Diabetes Endocrinology 52 Novel Therapeutic 52 Insulin resistance 52 Liver Failure 52 Myeloid 52 metabolic syndrome 52 Scientists Identify 52 Gastrointestinal Oncology 52 Atherosclerosis MESA 52 Hemorrhagic Stroke 52 Alzheimer Disease 52 Degeneration 52 Idiopathic Pulmonary Fibrosis 52 Colorectal Adenomas 52 Polyneuropathy 52 Hypertensive 52 Gene Mutation 52 Inhaled Corticosteroids 52 Polymorphisms 52 impaired glucose metabolism 52 Stenting 52 Renal Function 52 Continence Society 52 Angiotensin II 52 Hospital Acquired Pneumonia 52 Lung Cancer Trial 52 Intestinal 52 Iron Overload 52 Dasatinib 52 Laryngeal Cancer 52 Liver Diseases 52 Myelodysplastic Syndromes 52 Previously Treated 52 proliferative retinopathy 52 Mitral Regurgitation 52 Schizophrenia 52 Antiviral Therapy 52 Proves Effective 52 Secondary Hyperparathyroidism 52 Vertebral Fractures 52 Patients Undergoing 52 Amyloid 52 Trandolapril 52 gallstone disease 52 Venous Thrombosis 52 Aortic 52 Hip Fractures 52 Abdominal Fat 52 HDL Cholesterol 52 Metabolic Diseases 52 Prognostic Factors 52 Metabolic Disorders 52 Mortality Risk 52 T1DM 52 Emphysema 52 Hormone Therapy 52 Brain Shrinkage 52 Renal Failure 52 Tumor Microenvironment 52 Hematologic Malignancies 52 Proteinuria 52 Improve Survival 52 Esophageal Cancer 52 Tumor Progression 52 vascular inflammation 52 Coronary artery calcification 52 Catheter Associated 52 Serious Infections 52 Myelodysplastic Syndrome 52 Restenosis 52 Thyroid Cancer 52 Anemia 52 Obesity 52 cardiac fibrosis 52 HYVET 52 occlusive disease 52 subclinical atherosclerosis 52 Prevent Heart 52 Growth Hormone Deficiency 52 BERKELEY CA UroToday.com 52 geographic atrophy 52 Sepsis 52 intermittent claudication 52 Leukemias 52 myocardial ischemia 52 Coronary Disease 52 Metastatic 52 Postprandial 52 Arteriosclerosis Thrombosis 52 Neoplasia 52 Hepatic Encephalopathy 52 Signaling Pathways 52 Glucose Metabolism 52 Disease Progression 52 Malignancy 52 Attenuates 52 Reduces Mortality 52 LHON 52 Effectively Treats 52 Rhinosinusitis 52 Prolongs Survival 52 Clinical Trial Results 52 Ankylosing Spondylitis 52 Tiotropium 52 Vasculitis 52 elevated triglycerides 52 Valsartan 52 Recurrent Breast Cancer 52 Improve Outcomes 52 Genetic Disorders 52 Nicotine Vaccine 52 diabetes dyslipidemia 52 Diabetic Complications 52 progressive neurodegenerative disorder 52 Slow Progression 52 Adjuvant Chemotherapy 52 Bortezomib 52 Knee Osteoarthritis 52 atherothrombosis 52 MELAS 52 Macular Degeneration 52 hepatic steatosis 52 Stroke Risk 52 Coronary Artery 52 TTR amyloidosis 52 Childhood Asthma 52 Kidney Failure 52 Diabetic Macular Edema 52 Kidney Stones 52 Evaluation WISE 52 Anthracycline 52 Aneurysms 52 Progressive Multifocal Leukoencephalopathy 52 Autoantibodies 52 Nocturia 52 Chronic Myeloid Leukemia 52 Asymptomatic 52 Lipid Levels 52 Myoblast 52 Bone Marrow Transplantation 52 Homocysteine 51 Thrombocytopenia 51 Advanced Heart Failure 51 thromboembolic 51 Darapladib 51 Mitochondrial Dysfunction 51 Blood Cancers 51 Novel Method 51 Retrovirus 51 J Nutr 51 Androgen 51 Cell Adhesion 51 Myopathy 51 Acromegaly 51 Pharmacogenetics 51 Drug Shows Promise 51 Bipolar Disorders 51 Pooled Analysis 51 Islet Transplantation 51 Transcription Factor 51 Systemic Lupus Erythematosus 51 intracerebral hemorrhage ICH 51 Lung Cancer Screening 51 systolic hypertension 51 Neck Cancer 51 RNAi Therapeutics 51 Cerebrovascular Disease 51 Colorectal 51 Lumbar Spine 51 Carotid Intima Media 51 Beta Blockers 51 Tumor Growth 51 HIV Infection 51 Congenital 51 Scandinavian Simvastatin Survival 51 MPGN 51 Beta Amyloid 51 Neoplastic 51 Metabolomics 51 ASCO GI 51 Metastatic Prostate Cancer 51 coronary artery disease 51 microvascular disease 51 Oxidative stress 51 Cholesterol Levels 51 Adiponectin 51 Prenatal Diagnosis 51 Intervention Effectiveness 51 Protein Involved 51 Premature Aging 51 Anticoagulation 51 endometrial hyperplasia 51 SSc 51 Age Related Macular 51 Geriatric Medicine 51 Endovascular Therapy 51 Lymphoid 51 Cytotoxicity 51 Amyloidosis 51 Neurotoxicity 51 Lung Transplantation 51 Mitochondrial 51 Chronic Constipation 51 Drug Candidate 51 ADPKD 51 cardiovascular disease 51 Unresectable 51 periodontitis 51 Septic Shock 51 Stomach Cancer 51 amyloid plaque 51 glitazones 51 Chronic inflammation 51 lactic acidosis 51 Digestive Diseases 51 Artificial Pancreas 51 Refractory Angina 51 insulin resistance syndrome 51 Visceral Fat 51 amyloid deposits 51 angiotensin receptor blockers 51 Chronic Bronchitis 51 Erythropoietic 51 Congenital Heart Disease 51 Chronic HCV 51 Peptic Ulcer 51 Diabetes EASD 51 Gastrointestinal 51 Myeloproliferative Disorders 51 Recurrent Stroke 51 Prospective Multicenter 51 Chronic Prostatitis 51 artery stenosis 51 Cell Signalling 51 Estrogen Receptor 51 Uterine Fibroids 51 Albuminuria 51 cerebral vasospasm 51 Arch Neurol 51 alcoholic fatty liver 51 arterial hypertension 51 Targeted Therapy 51 Chronic Diseases 51 cholinesterase inhibitors 51 Chronic Lymphocytic Leukemia CLL 51 Genetic Variations 51 Endocrinol 51 Rheumatoid Arthritis Patients 51 Hydroxyurea 51 occlusion CRVO 51 Reperfusion Injury 51 Exacerbations 51 Squamous Cell Carcinoma 51 Cilostazol 51 Enalapril 51 Gene Linked 51 Malignant Glioma 51 Metastasis 51 Resistant Hypertension 51 2 diabetes T2D 51 Chronic Insomnia 51 Ischaemic heart 51 Hyperthyroidism 51 Endocarditis 51 Stent Thrombosis 51 Sipuleucel T 51 familial amyloidotic polyneuropathy FAP 51 Psychiatric Services #:#-#,# 51 proliferative diabetic retinopathy 51 Atopic Dermatitis 51 Osteoarthritis Patients 51 Statin Use 51 Cardiomyopathy 51 Diabetic neuropathy 51 Increased Risk 51 Microvascular 51 pulmonary hypertension PH 51 Statin therapy 51 Breast Cancer Risk 51 Excessive Sweating 51 Neurogenesis 51 Cerebellar 51 Anticancer 51 Genes Identified 51 fibrotic disease 51 Researchers Identify 51 Mucositis 51 Critical Limb Ischemia 51 Lung Cancer 51 Placebo Controlled Study 51 retinal vein occlusion 51 Cardiac Rhythm 51 Oxidative 51 atherogenesis 51 Smooth Muscle 51 Pathophysiology 51 Inflammatory Response 51 Bronchiolitis 51 Gestational Diabetes 51 arterial calcification 51 Papillary 51 Hypertensive Patients 51 Chronic lymphocytic leukemia 51 Nuclear Receptors 51 Hyperthermia 51 Arterial Hypertension 51 Glycation 51 #:#-# [023] 51 Gaucher Disease 51 lung fibrosis 51 arterial plaque 51 Cardiovascular Risk Factors 51 Lp PLA 2 51 Signal Transduction 51 Pleural Mesothelioma 51 Unstable Angina 51 Neurologic 51 Gene Variant 51 Renal Anemia 51 #:#-# [037] 51 Bronchial Asthma 51 atherosclerotic cardiovascular disease 51 B Cell Lymphoma 51 Prematurity 51 Small Molecule 51 Cystic 51 Liver Metastases 51 Cutaneous 50 Lipid Research 50 Aggressive Prostate Cancer 50 Colorectal Cancer Screening 50 INCB# [003] 50 Nephrogenic 50 Keratitis 50 Liver Injury 50 idiopathic pulmonary fibrosis IPF 50 systemic amyloidosis 50 Hepatocellular 50 Glycemic Control 50 Medullary 50 Hyperparathyroidism 50 TNF Alpha 50 Cardiovascular Disease Risk 50 myelofibrosis polycythemia vera 50 Newly Diagnosed Multiple Myeloma 50 MassGeneral Institute 50 autoimmune thyroid 50 Peptide YY 50 Chronic Rhinosinusitis 50 Lung Tumors 50 Neutropenia 50 Genetic Markers 50 Breast Tumors 50 Dementias 50 SPARCL 50 familial adenomatous polyposis 50 Adrenal 50 coronary heart 50 Subtypes 50 Chronic Sinusitis 50 hereditary deafness 50 Acute Coronary Syndromes 50 Lung Cancers 50 Cancer Therapies 50 #:#-# [007] 50 Progenitor Cells 50 Pharmacokinetics 50 APOL1 50 macrovascular events 50 acute PAO 50 Improves Outcomes 50 Innate Immunity 50 Poorly Controlled 50 Gliomas 50 colorectal carcinoma 50 atherosclerotic plaques 50 Premenopausal Women 50 ischemic strokes 50 Sezary syndrome 50 MGUS 50 Endocrine Surgery 50 angiotensin converting enzyme inhibitors 50 Peripheral artery disease 50 Endometrial Cancer 50 Gynecologic 50 Hemorrhagic 50 obesity insulin resistance 50 Improves Survival 50 Gene Variation 50 Viral Infections 50 Multicenter Trial 50 Immune Responses 50 Certain Cancers 50 Endothelial dysfunction 50 Am J Clin 50 Hyperuricemia 50 Gastrointestinal Cancers 50 Neuroinflammation 50 Short Stature 50 Stable Coronary Artery 50 Neonatal Diabetes 50 dilated cardiomyopathy DCM 50 Beta Blocker 50 Skin Cancers 50 UroToday.com 50 Clinical Outcomes 50 Follicular Lymphoma 50 Carotid Revascularization Endarterectomy vs. 50 Prostate Cancer Treatment 50 Pharmacologic 50 Randomized Double blind 50 FTLD 50 Novel Mechanism 50 Improve Diagnosis 50 Low Incidence 50 fatty liver disease 50 Suicidality 50 Rosuvastatin 50 improves insulin sensitivity 50 cardiac dysfunction 50 Microplasmin 50 Complication Rates 50 Motility 50 Nephropathy 50 Acute Myocardial Infarction AMI 50 T2D 50 Electrical Stimulation 50 nephrogenic fibrosing dermopathy 50 Diabetes 50 Tissue Engineering 50 vascular disease 50 muscular dystrophies 50 Psoriatic 50 vWD 50 Prostate Cancers 50 Hypertrophic cardiomyopathy 50 Brain Stimulation 50 Gastrointestinal Disorders 50 General Psychiatry #:#-#,# 50 hepatocellular carcinoma 50 Tyrosine Kinase Inhibitor 50 colorectal adenoma 50 Cannabinoid 50 Percutaneous Coronary Intervention 50 PKC beta 50 telomere dysfunction 50 metabolic syndrome MetS 50 thromboembolism 50 Epileptic Seizures 50 soluble CD# ligand 50 Neuronal 50 neurofibrillary tangles 50 Calcium Intake 50 Hepatitis C Virus 50 Breast Cancers 50 Early Diagnosis 50 Anti Tumor 50 Hormone Refractory Prostate Cancer 50 Nat Genet 50 Vascular Ultrasound 50 Clinical Implications 50 amyloid deposition 50 Angioedema 50 myocardial infarction 50 Immunodeficiencies 50 giant cell arteritis 50 Acute Renal Failure 50 macrovascular disease 50 Pediatric Rheumatology 50 losartan 50 atherosclerosis hardening 50 valvular heart 50 C Reactive Protein 50 diabetes hyperlipidemia 50 diabetic retinopathy 50 Blood Clots 50 Pharmacological Research 50 Hyperphosphatemia 50 Osteoporosis Drugs 50 tolvaptan 50 liver fibrosis 50 Bisphosphonates 50 Lung Cancer Survival 50 Renal Diseases 50 Novel Therapeutics 50 channelopathies 50 CP CPPS 50 gastrointestinal stromal tumor 50 Anti Angiogenic 50 Rheumatoid Arthritis RA 50 Treatment Resistant 50 SHPT 50 Stem Cell Treatment 50 Antipsychotic 50 Sarcopenia 50 Neuroendocrine Tumor 50 hemorrhagic strokes 50 High Blood Pressure 50 Stress Induced 50 Fungal Infections 50 iron overload 50 Fatty liver 50 Diastolic Heart Failure 50 Acute Coronary Syndrome 50 Randomized Phase II 50 neovascularization 50 Metabolic Disorder 50 Advanced Ovarian Cancer 50 serum leptin 50 Prostate Cancer Survival 50 Nutrition Metabolism 50 artherosclerosis 50 Diet Induced 50 valvular disease 50 hypercalciuria 50 axonal damage 50 Multicenter 50 Thoracic Aortic Aneurysms 50 Colorectal Cancer Risk 50 Circulatory 50 Alcohol Consumption 50 Brain Tumors 50 Statin Drugs 50 Vitamin D Deficiency 50 lipodystrophy 50 subclinical hypothyroidism 50 Biomarker 50 Lowers Cholesterol 50 Oxidative damage 50 secondary hyperparathyroidism 50 Triglyceride 50 Nesiritide 50 Ovarian Cancer Screening 50 Neovascular AMD 50 Interstitial Cystitis 50 Aldosterone 50 FASEB J. 50 CARDIA 50 Prostate Cancer Recurrence 50 Rectal Cancer 50 Neurodevelopmental 50 Neoadjuvant Chemotherapy 50 cystic fibrosis chronic pancreatitis 50 #:#-# [031] 50 cachexia 50 Anxiety Disorders 50 Neuroendocrine 50 Bacterial Infections 50 Cellular Immunotherapy 50 Rhabdomyolysis 50 Asthma COPD 50 Prognostic Significance 50 Late Breaker 50 candesartan 50 carotid plaque 50 Fibroblast 50 Reduced Risk 50 Childhood Leukemia 50 Investigational Compound 50 Hemodialysis Patients 50 Therapeutic Efficacy 50 Adjuvant Therapy 50 hyperinsulinemia 50 liver scarring 50 Coronary Intervention 50 Therapy Evaluation 50 Phase 2b Clinical Trial 50 Hormone Replacement 50 telomere shortening 50 Mimetics 50 Breast Cancer Cells 50 Preclinical Study 50 Critical limb ischemia 50 Pre eclampsia 50 Chronic Inflammation 49 Alzheimer Disease AD 49 Vascular Biology 49 Shy Drager syndrome 49 EMBO J. 49 Medulloblastoma 49 Abnormalities 49 non alcoholic steatohepatitis 49 Study AREDS 49 Cell Proliferation 49 Neovascularization 49 Mild Cognitive Impairment 49 cardiovascular mortality 49 Dehydrogenase 49 Glycemia 49 Cancer Immunotherapy 49 Biological Therapy 49 Cerebral Cortex 49 Autologous Stem Cell Transplantation 49 plasma kallikrein 49 Captopril 49 Neuroendocrinology 49 Spine Patient Outcomes 49 Cancer Incidence Mortality 49 Drugs Affecting Lipid 49 thromboembolic disease 49 Liver Transplantation 49 Systemic Sclerosis 49 Social Phobia 49 Sclerosis 49 Inhaled Liposomal Ciprofloxacin 49 Digestive Disease 49 Diabetic retinopathy 49 Immunobiology 49 pulmonary hypertension 49 Ulcerative colitis 49 Advanced Pancreatic Cancer 49 Patients Suffering 49 beta amyloid peptide 49 Genes Linked 49 Paroxysmal 49 ARVD 49 fatty plaques 49 Benign Prostatic Hyperplasia BPH 49 cardiovascular morbidity 49 Cardiac Arrhythmia 49 Therapeutic Potential 49 choroidal neovascularization 49 Pancreatic Cancer 49 Hypophosphatasia 49 Kidney Disease Outcomes 49 Natalizumab 49 Systolic Hypertension 49 Arthritis Musculoskeletal 49 Retinitis pigmentosa 49 elevated triglyceride levels 49 Preclinical Models 49 hyperkalemia 49 kidney urologic 49 Galectin 3 49 Toxicogenomics 49 Systemic Delivery 49 Lung Cancer Patients 49 Brain Atrophy 49 Neuroepidemiology 49 Myocardial infarction 49 Venous Thromboembolism VTE 49 Gene Therapy 49 Malignant Pleural Mesothelioma 49 Differential Diagnosis 49 basal cell nevus syndrome 49 dyslipidaemia 49 Muscle Function 49 Angina 49 rare autosomal recessive 49 RCW Breast Cancer 49 Paroxysmal Nocturnal Hemoglobinuria PNH 49 diabetes mellitus DM 49 Mineral Research ASBMR 49 LV dysfunction 49 intimal hyperplasia 49 aortic valve stenosis 49 esophageal squamous cell carcinoma 49 Menopausal Symptoms 49 induce orthostatic hypotension 49 Ovarian Cancers 49 Cardiovascular Sciences